Stay updated on Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Adds a new bibliographic citation for a 2026 article on quality-adjusted survival in pembrolizumab plus chemotherapy for advanced esophageal cancer to the Publications section, and updates the page’s revision history from 3.6.2 to 3.6.3.
    Difference
    0.0%
    Check dated 2026-07-06T15:48:55.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision tag updated to v3.6.2, indicating a newer release of the page content.
    Difference
    0.0%
    Check dated 2026-06-29T08:51:33.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Recruitment is now closed, signaling that no further participants are being recruited for the study. The page also includes new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and shows a revision update to v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-14T18:28:12.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5 on the page, signaling a small version update to the underlying template. There is no indication of changes to visible content or functionality.
    Difference
    0.0%
    Check dated 2026-06-07T12:46:48.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A new publication citation for a 2024 Oncologist article analyzing health-related quality of life in KEYNOTE-590 was added to the Publications section, and an earlier erratum entry related to that article was removed/updated.
    Difference
    0.0%
    Check dated 2026-05-15T23:55:50.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The locations list adds Taoyuan, Taiwan, 333 (replacing Taoyuan District, Taiwan, 333) to represent a new trial site; a 2026 publication citation about KEYNOTE-590 was added to Publications.
    Difference
    0.0%
    Check dated 2026-05-01T21:35:04.000Z thumbnail image

Stay in the know with updates to Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.